Quince Therapeutics
QNCX
$0.96
Share price
-2.55%
Change (1 day)
-41.10%
Change (1 year)
Categories
EPS for Quince Therapeutics (QNCX)
EPS in 2023 (TTM): -$0.83
According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.83. In 2022 the company made an earnings per share (EPS) of -$1.58 an increase over its 2021 EPS that were of -$3.03.
EPS history for Quince Therapeutics from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.83 | -47.47% |
| 2022 | -$1.58 | -47.85% |
| 2021 | -$3.03 | 15.21% |
| 2020 | -$2.63 | 62.51% |
| 2019 | -$1.62 | 179.56% |
| 2018 | -$0.58 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 162.65% | 🇺🇸 USA |